|
|
|
chromic acid
CAS #: 7738-94-5
Cancer Risk Information
1986 USEPA Cancer Risk Category: Group A-Human Carcinogen
Interpreting Cancer Risk HTML PDF
Species and Tumor Types: Dose-response relationships have been established for chromium exposure and lung cancer in humans. Hexavalent chromium compounds are carcinogenic in human bioassays, producing the following tumor types: intramuscular injection site tumors in rats and mice, intrapleural implant site tumors for various Cr(VI) compounds in rats, intrabronchial implantation site tumors for various Cr(VI) compounds in rats, and subcutaneous injection site sarcomas in rats. The oral carcinogenicity of Cr(IV) cannot be determined. No data were located in the available literature that suggested that Cr(VI) is carcinogenic by oral route of exposure.
NOTE: Cancer risk classifications are specific to active ingredients, not products. To arrive at an overall health or cancer risk evaluation for a pesticide product, active ingredient cancer risk information should be used together with other risk and exposure information, such as USEPA Risk Management Decision Documents (REDs, IREDs, TREDs, and others).
USEPA Risk Management Documents
USEPA risk management decision documents provide chemical-specific risk assessment information for active ingredients evaluated by the USEPA for use in pesticide products. For more information, see Pesticide Registration HTML.
Products
In New York State, chromic acid is found in:
Program on Breast Cancer and Environmental Risk Factors
Cornell University, College of Veterinary Medicine
Vet Box 31, Ithaca, NY 14853-6401
Phone: 607.254.2893; Fax: 607.254.4730
Email: breastcancer@cornell.edu
We comply with the HONcode standard for
trustworthy health information: Verify here.
